CpG oligodeoxynucleotides potentiate the antitumor activity of anti‐ BST 2 antibody-Reference-Cited by-同舟云学术

CpG oligodeoxynucleotides potentiate the antitumor activity of anti‐ BST 2 antibody

Published:2015-10 Issue:10 Volume:106 Page:1474-1478
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Hiramatsu Kosuke¹²,Serada Satoshi²,Kobiyama Kouji³,Nakagawa Satoshi¹²,Morimoto Akiko¹,Matsuzaki Shinya¹,Ueda Yutaka¹,Fujimoto Minoru²,Yoshino Kiyoshi¹,Ishii Ken J.³,Enomoto Takayuki⁴,Kimura Tadashi¹,Naka Tetsuji²

Affiliation:

1. Department of Obstetrics and Gynecology Osaka University Graduate School of Medicine Suita Japan

2. Laboratory of Immune Signal National Institute of Biomedical Innovation, Health and Nutrition Ibaraki Japan

3. Laboratory of Adjuvant Innovation National Institute of Biomedical Innovation, Health and Nutrition Ibaraki Japan

4. Department of Obstetrics and Gynecology Niigata University Medical School Niigata Japan

Funder

Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12738

Reference12 articles.

1. Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

2. Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer

3. Prognostic value of intratumoral natural killer cells in gastric carcinoma

4. Cancer-Induced Immunosuppression: IL-18–Elicited Immunoablative NK Cells

5. Toll-like receptors: critical proteins linking innate and acquired immunity

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone marrow stromal cell antigen 2: Tumor biology, signaling pathway and therapeutic targeting (Review);Oncology Reports;2024-01-18

2. Engineered CpG‐Loaded Nanorobots Drive Autophagy‐Mediated Immunity for TLR9‐Positive Cancer Therapy;Advanced Materials;2023-12-06

3. Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody;Anticancer Research;2023-05-29

4. Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissue;PLOS ONE;2023-03-13

5. Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line;Frontiers in Molecular Biosciences;2020-12-18